Geneesmiddelen in ATC-groep L — Antineoplastische en immunomodulerende middelen
Overzicht van geneesmiddelen in ATC-klasse L (Antineoplastische en immunomodulerende middelen) en hun beschikbaarheid in Belgische apotheken.
1878 geneesmiddelen
- Irinosin 20 mg/ml
- Irinosin 20 mg/ml
- Irinosin 20 mg/ml
- Irinotecan Accord 20 mg/ml — irinotecan
- Irinotecan Accord 20 mg/ml — irinotecan
- Irinotecan Accord 20 mg/ml — irinotecan
- Irinotecan Accord 20 mg/ml — irinotecan
- Irinotecan Accord 20 mg/ml — irinotecan
- Irinotecan EG 20 mg/ml
- Irinotecan EG 20 mg/ml
- Irinotecan EG 20 mg/ml
- Irinotecan Eugia 20 mg/ml — irinotecan
- Irinotecan Eugia 20 mg/ml — irinotecan
- Irinotecan Eugia 20 mg/ml — irinotecan
- Irinotecan Eugia 20 mg/ml — irinotecan
- Irinotecan Hikma Farmaceutica 20 mg/ml — irinotecan
- Irinotecan Hikma Farmaceutica 20 mg/ml
- Irinotecan Hikma Farmaceutica 20 mg/ml — irinotecan
- Irinotecan Kabi 20 mg/ml — irinotecan
- Irinotecan Kabi 20 mg/ml — irinotecan
- Irinotecan Kabi 20 mg/ml — irinotecan
- Irinotecan Kabi 20 mg/ml — irinotecan
- Irinotecan Sandoz 20 mg/ml
- Irinotecan Sandoz 20 mg/ml
- Irinotecan Sandoz 20 mg/ml
- Irinotecan Sandoz 20 mg/ml
- Irinotecan Vianex 100 mg/5 ml
- Irinotecan Vianex 40 mg/2 ml
- Irinotecan Viatris 100 mg/5 ml
- Irinotecan Viatris 300 mg/15 ml — irinotecan
- Irinotecan Viatris 500 mg/25 ml — irinotecan
- Itovebi 3 mg
- Itovebi 9 mg
- Jakavi 10 mg — ruxolitinib
- Jakavi 15 mg — ruxolitinib
- Jakavi 20 mg — ruxolitinib
- Jakavi 5 mg — ruxolitinib
- Jakavi 5 mg/ml — ruxolitinib
- Jaypirca 100 mg — pirtobrutinib
- Jemperli 500 mg — dostarlimab
- Jevtana 60 mg — cabazitaxel
- Jyseleca 100 mg — filgotinib
- Jyseleca 100 mg — filgotinib
- Jyseleca 200 mg — filgotinib
- Jyseleca 200 mg — filgotinib
- Jyseleca 200 mg — filgotinib
- Jyseleca 200 mg — filgotinib
- Jyseleca 200 mg — filgotinib
- Kadcyla 100 mg — trastuzumab emtansine
- Kadcyla 160 mg — trastuzumab emtansine
- Kanjinti 150 mg — trastuzumab
- Kanjinti 420 mg — trastuzumab
- Kesimpta 20 mg — ofatumumab
- Kesimpta 20 mg — ofatumumab
- Kesimpta 20 mg — ofatumumab
- Kesimpta 20 mg — ofatumumab
- Kevzara 150 mg — sarilumab
- Kevzara 150 mg — sarilumab
- Kevzara 150 mg — sarilumab
- Kevzara 200 mg — sarilumab